Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): Crossover pilot study (J-VICTORIA study)

BACKGROUND: No previous studies have compared the DPP-4 inhibitors vildagliptin and sitagliptin in terms of blood glucose levels using continuous glucose monitoring (CGM) and cardiovascular parameters. METHODS: Twenty patients with type 2 diabetes mellitus were randomly allocated to groups who recei...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakamoto, Masaya, Nishimura, Rimei, Irako, Taiga, Tsujino, Daisuke, Ando, Kiyotaka, Utsunomiya, Kazunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471040/
https://www.ncbi.nlm.nih.gov/pubmed/22867630
http://dx.doi.org/10.1186/1475-2840-11-92

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471040/
https://www.ncbi.nlm.nih.gov/pubmed/22867630
http://dx.doi.org/10.1186/1475-2840-11-92

Ejemplares similares